Cellectar Biosciences, Inc. · NASDAQ:CLRB
Nantahala Capital Management, LLC's stake in Cellectar Biosciences, Inc. fell to 0.06% (Schedule 13G/A)
Event Jun 30, 2025 · Filed Aug 14, 2025
Nantahala Capital Management, LLC's stake in Cellectar Biosciences, Inc. fell to 0.06%, 1,109 shares, as a passive investor on Jun 30, 2025. Filed Aug 14, 2025 (Schedule 13G/A).
- Stake
- 0.06%
- Shares
- 1,109
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Nantahala Capital Management, LLC | 0.06% | 1,109 |
| Wilmot B. Harkey | 0.06% | 1,109 |
| Daniel Mack | 0.06% | 1,109 |
Source
Related
- Cellectar Biosciences, Inc.
- Nantahala Capital Management, LLC
- Cellectar Biosciences, Inc. shareholders
- Schedule 13G · Stempoint Capital LP · Aug 14, 2026
- Schedule 13G · Silverarc Capital Management, LLC · Aug 14, 2026
- Schedule 13G · Balyasny Asset Management L.P. · Aug 14, 2026
- Schedule 13G · Caligan Partners LP · Aug 14, 2026
- Schedule 13G · Bleichroeder LP · Aug 13, 2026